- Home
- NRO vs VIGL Comparison
NRO vs VIGL Comparison
Compare NRO & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRO
- VIGL
- Stock Information
- Founded
- NRO 2003
- VIGL 2020
- Country
- NRO United States
- VIGL United States
- Employees
- NRO N/A
- VIGL N/A
- Industry
- NRO Finance/Investors Services
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- NRO Finance
- VIGL Health Care
- Exchange
- NRO Nasdaq
- VIGL Nasdaq
- Market Cap
- NRO 156.7M
- VIGL 134.9M
- IPO Year
- NRO N/A
- VIGL 2022
- Fundamental
- Price
- NRO $3.20
- VIGL $8.07
- Analyst Decision
- NRO
- VIGL Buy
- Analyst Count
- NRO 0
- VIGL 7
- Target Price
- NRO N/A
- VIGL $8.00
- AVG Volume (30 Days)
- NRO 239.4K
- VIGL 830.8K
- Earning Date
- NRO 01-01-0001
- VIGL 08-12-2025
- Dividend Yield
- NRO 11.41%
- VIGL N/A
- EPS Growth
- NRO N/A
- VIGL N/A
- EPS
- NRO N/A
- VIGL N/A
- Revenue
- NRO N/A
- VIGL N/A
- Revenue This Year
- NRO N/A
- VIGL N/A
- Revenue Next Year
- NRO N/A
- VIGL N/A
- P/E Ratio
- NRO N/A
- VIGL N/A
- Revenue Growth
- NRO N/A
- VIGL N/A
- 52 Week Low
- NRO $2.51
- VIGL $1.31
- 52 Week High
- NRO $3.45
- VIGL $8.10
- Technical
- Relative Strength Index (RSI)
- NRO 45.54
- VIGL 88.16
- Support Level
- NRO $3.19
- VIGL $8.03
- Resistance Level
- NRO $3.27
- VIGL $8.10
- Average True Range (ATR)
- NRO 0.03
- VIGL 0.03
- MACD
- NRO -0.01
- VIGL -0.10
- Stochastic Oscillator
- NRO 12.50
- VIGL 87.56
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.